Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy

Mesenchymal stromal cells (MSCs) are multipotent cells with anti-inflammatory properties. Here we tested the safety of MSCs in patients with progressive supranuclear palsy (PSP; ClinicalTrials.gov: NCT01824121; Eudract No. 2011-004051-39). Seven patients were treated. To improve the safety, protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Rosaria, Canesi, Margherita, Isalberti, Maurizio, Marfia, Giovanni, Campanella, Rolando, Vincenti, Daniele, Cereda, Viviana, Ranghetti, Alessandra, Palmisano, Chiara, Isaias, Ioannis Ugo, Benti, Riccardo, Marotta, Giorgio, Lazzari, Lorenza, Montemurro, Tiziana, Viganò, Mariele, Budelli, Silvia, Montelatici, Elisa, Lavazza, Cristiana, Rivera-Ordaz, Araceli, Pezzoli, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546103/
https://www.ncbi.nlm.nih.gov/pubmed/34712113
http://dx.doi.org/10.3389/fnins.2021.723227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546103/
https://www.ncbi.nlm.nih.gov/pubmed/34712113
http://dx.doi.org/10.3389/fnins.2021.723227

Ejemplares similares